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A B S T R A C T
The recent outbreak of infection with Zika virus (ZIKV; Flaviviridae) has attracted attention to this
previously neglected mosquito-borne pathogen and the need for efﬁcient therapies. Since ﬂavivirus
replication is generally known to be dependent on fatty acid biosynthesis, two inhibitors of this pathway,
5-(tetradecyloxyl)-2-furoic acid (TOFA) and cerulenin, were tested for their potentiality to inhibit virus
replication. At concentrations previously shown to inhibit the replication of other ﬂaviviruses, neither
drug had a signiﬁcant antiviral affect against ZIKV, but reduced the replication of the non-related
mosquito-borne Semliki Forest virus (Togaviridae).
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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journa l homepage: www.e lsev ier .com/ locate / tv j lArboviruses are a diverse group of viruses that are transmitted
by arthropod vectors, including mosquitoes, ticks and midges and
belong to four main viral families (Togaviridae, Flaviviridae,
Bunyaviridae and Reoviridae). In the Flaviviridae (genus Flavivirus),
important and/or representative viruses include Zika virus (ZIKV)
and dengue virus (DENV), whilst the genus Alphavirus in the
Togaviridae family contains chikungunya virus (CHIKV) and Semliki
Forest virus (SFV). Arbovirus infections can cause severe disease in
a range of human and animal hosts, resulting in a signiﬁcant social
and economic impact in many areas of the world (Weaver and
Reisen, 2010).
The recent outbreak of infection with Zika virus (ZIKV,
Flaviviridae) in human beings has brought increased attention to
previously this neglected arboviruses. ZIKV is thought to be mainly
spread by Aedes aegypti mosquitoes in the South American
outbreak (Ferreira-de-Brito et al., 2016). Symptoms of infection
in human beings are generally mild, consisting of fever and joint
pain. However, infection during pregnancy can cause microcephaly
and other manifestations that are grouped as Zika congenital
syndrome, while infection in adults has been linked to Guillain-
Barré syndrome (Russo et al., 2017).
The replication of several ﬂaviviruses, including DENV and
alphaviruses (CHIKV), is dependent on continuous synthesis of
fatty acids; the use of chemicals to inhibit their production has
been shown to decrease virus production (Heaton et al., 2010;* Corresponding author.
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antiviral agents, as has been postulated for ﬂaviviruses, including
ZIKV (Martin-Acebes et al., 2016). Fatty acid synthesis in the
cytoplasm of eukaryotic cells requires three different enzymes that
act in an orchestrated manner: ATP citrate lyase (ACLY), acetyl-CoA
carboxylase (ACC) and fatty acid synthase (FASN). Here we aimed
to assess if ZIKV replication could be restricted through the
treatment of infected cells with drugs that inhibit fatty acid
biosynthesis. To this end we used 5-(tetradecyloxyl)-2-furoic acid
(TOFA; Sigma–Aldrich) and cerulenin (Sigma–Aldrich), which
inhibit ACC and FASN, respectively.
Firstly, the toxicity of the drugs was tested on adenocarcinomic
human alveolar basal epithelial (A549) cells grown in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% foetal
bovine serum. Cell viability was assessed by measuring ATP levels
using the CellTitre-Glo Luminescent Cell Viability Assay (Promega).
At 8 h after the addition of the drug, cells treated with cerulenin
exhibited reduced viability. This effect was more prominent after
24 h. However, treatment with TOFA did not decrease cell viability
(Fig. 1A, top and lower panels).
Secondly, to study the inhibitory effect of these drugs on ZIKV
replication, A549 cells were infected with a generic Asian strain-
derived ZIKV expressing nanoluciferase (Nluc) followed by foot-
and-mouth disease virus 2A autoprotease, ubiquitin sequence
(Fig. 1B); these elements are required to liberate Nluc from
duplicated capsid protein C. The cells were infected at a
multiplicity of infection (MOI) of 0.1 or 1 and the drugs applied
at either 4 or 16 h post-infection (hpi), respectively. Due to the
toxicity of cerulenin, cells were lysed 8 h post-treatment and Nlucle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. (A) A549 cells were treated with different concentrations of drugs for 8 or 24 h. Dimethyl sulphoxide (DMSO) was used as a negative control and cell viability was
measured using a CellTitre-Glo Luminescent Cell Viability Assay kit. The experiment was repeated independently three times. (B) Representation of reporter viruses: (1) Zika
virus expressing nanoluciferase (ZIKV-NlucUbi); and (2) Semliki Forest virus expressing ﬁreﬂy luciferase (SFV4(3H)-FFLuc). (C) A549 cells were infected with SFV4(3H)-FFLuc
at a multiplicity of infection (MOI) of 1 and drugs were added at 1 h post-infection (hpi). After 8 hpi, the cells were lysed and ﬁreﬂy luciferase (FFLuc) activity was measured.
(D) A549 cells were infected with ZIKV-NLucUbi at MOIs of 0.1 or 1 and drugs were added at 1, 4 or 16 h. Cells were lysed after either 12 or 24 hpi and nanoluciferase (Nluc)
activity was measured. Experiments in (C) and (D) were conducted independently twice in quadruplicate; the relative mean values with standard errors are depicted. (E)
A549 cells were infected with Brazilian ZIKV strain PE243 at a MOI of 1. Drugs were added either 1 or 4 hpi; total RNA was isolated at 12 or 24 hpi, respectively. Genomic RNA
levels were analysed by reverse transcriptase quantitative PCR (RT-qPCR) using cellular glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene as an internal control. The
experiment was repeated independently three times and the relative mean values with standard error are depicted. *P < 0.01 in Student’s t test.
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compared ZIKV to a recombinant strain of SFV expressing cleavable
ﬁreﬂy luciferase (FFLuc; designated SFV4(3H)-FFLuc) (Fig. 1B).
A549 cells were infected at a MOI of 1 and drugs were added 1 hpi.
As expected, both cerulenin and TOFA inhibited SFV; this effect
was concentration dependent, since higher concentrations
resulted in reduced luciferase amounts (Fig. 1C). Similar effects
have been shown previously for CHIKV (Karlas et al., 2016), a close
relative of SFV. The results of TOFA treatment on ZIKV showed that,
if Nluc levels were measured 12 hpi (Fig. 1D, MOI 1, drugs added at
4 hpi) at the highest drug concentration, only a 20% reduction in
Nluc levels was observed, thus indicating a weak decrease in ZIKV
replication. This weak effect was also present when cells were
lysed at 24 hpi (Fig. 1D, MOI 0.1, drugs added at 16 hpi). However,
regardless of the concentration of cerulenin used, there was no
decrease in Nluc levels. This suggested there was no effect of this
drug on ZIKV replication.
These results were unexpected, since the dependence of
ﬂaviviruses on lipid biosynthesis is well documented. We therefore
performed a further experiment, whereby A549 cells were infected
at a MOI of 1, with drugs added at 1 hpi and Nluc activity measured
at 24 hpi. TOFA was again found to have antiviral effects only at the
highest concentration, resulting in a weak, non-signiﬁcant, 20%
reduction in luciferase (Fig. 1D). However, despite its observed
toxicity, cerulenin did not decrease virus replication.
To conﬁrm these ﬁndings, cells were infected with the wild-
type Brazilian strain ZIKV PE243 (Donald et al., 2016) at an MOI of 1.
Cells were then treated with both drugs either at 1 or 4 hpi and
total RNA was collected at 12 or 24 hpi. Using reverse transcriptase
(RT) quantitative PCR (RT-qPCR), we found that neither cerulenin
nor TOFA decreased virus genomic RNA levels signiﬁcantly (except
for a weak reduction at 12 hpi with cerulenin), thereby suggesting
that neither drug affects virus replication (Fig. 1E). The resistance
of ZIKV in A549 cells under the conditions tested here was
unexpected, since dependence on ACC and FASN has been shown
for different ﬂaviviruses including DENV and hepatitis C virus
(HCV) (Yang et al., 2008; Heaton et al., 2010). However, both DENV
and HCV infections are known to increase production of fatty acids
and higher levels of FASN expression.
It is therefore possible that heightened production of FASN
could occur in ZIKV infected cells, which may result in relativeinsensitivity to drugs. Both drugs had the expected antiviral effects
against SFV infection and targeting fatty acids synthesis may be
one way to treat alphavirus infections. However, a more detailed
analysis of the metabolic activities in cells associated with ZIKV is
required.
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